Myriad Genetics Inc MYD-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:03 AM CEST
21.04quote price arrow down-0.28 (-1.31%)
52 week range
18.60 - 30.87
Loading...
  • Open21.04
  • Day High21.04
  • Day Low21.04
  • Prev Close23.33
  • 52 Week High30.87
  • 52 Week High Date08/30/21
  • 52 Week Low18.60
  • 52 Week Low Date05/10/22

Key Stats

  • Market Cap1,796.31M
  • Shares Out80.3M
  • 10 Day Average Volume80
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.17

KEY STATS

  • Open21.04
  • Day High21.04
  • Day Low21.04
  • Prev Close23.33
  • 52 Week High30.87
  • 52 Week High Date08/30/21
  • 52 Week Low18.60
  • 52 Week Low Date05/10/22
  • Market Cap1,796.31M
  • Shares Out80.3M
  • 10 Day Average Volume80
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.17

RATIOS/PROFITABILITY

  • EPS (TTM)-0.05
  • P/E (TTM)-420.80
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Myriad Genetics Inc

There is no recent news for this security.

Profile

MORE
Myriad Genetics, Inc. is a genetic testing and precision medicine company. The Company primarily provides testing and collaborative development of testing that is designed to assess an individual’s risk for developing the disease later in life, identify a patient’s likelihood of responding to drug therapy and guide a patient’s dosing to ensure optimal treatment, or assess a patient’s risk of disease progression, and includes corporate services, such as finance, human...
S. Louise Phanstiel CPA
Independent Chairman of the Board
Paul Diaz
President, Chief Executive Officer, Director
Nicole Lambert
Chief Operating Officer
R. Bryan Riggsbee
Chief Financial Officer, Treasurer
Kevin Haas
Chief Technology Officer
Address
320 S Wakara Way
Salt Lake City, UT
84108-1214
United States